Clinical trial
Evaluation of Liposomal Bipivicaine in Split Thickness Skin Graft Donor Sites in Burn Patients
NCT03705637 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Liposomal Bipivicaine in Split Thickness Skin Graft Donor Sites in Burn Patients
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- June 1, 2019
- Completion date
- March 24, 2020
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.